Page last updated: 2024-11-04

terazosin and Cardiomyopathies, Primary

terazosin has been researched along with Cardiomyopathies, Primary in 1 studies

Terazosin: induces decreased blood pressure; used in the treatment of benign prostatic hyperplasia

Research Excerpts

ExcerptRelevanceReference
"We describe a 71-year-old male patient who developed acute myocardial infarction (AMI) due to a dynamic left ventricular outflow tract obstruction induced by terazosin."7.83Myocardial infarction induced by oral terazosin in a patient with predisposing structural cardiomyopathy: case report. ( Ferrando-Castagnetto, F; Lluberas, N; Martínez, F; Vidal Margenat, A; Vignolo, G, 2016)
"We describe a 71-year-old male patient who developed acute myocardial infarction (AMI) due to a dynamic left ventricular outflow tract obstruction induced by terazosin."3.83Myocardial infarction induced by oral terazosin in a patient with predisposing structural cardiomyopathy: case report. ( Ferrando-Castagnetto, F; Lluberas, N; Martínez, F; Vidal Margenat, A; Vignolo, G, 2016)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Vidal Margenat, A1
Ferrando-Castagnetto, F1
Martínez, F1
Lluberas, N1
Vignolo, G1

Other Studies

1 other study available for terazosin and Cardiomyopathies, Primary

ArticleYear
Myocardial infarction induced by oral terazosin in a patient with predisposing structural cardiomyopathy: case report.
    Medwave, 2016, Jun-28, Volume: 16, Issue:5

    Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Angina Pectoris; Cardiomyopathies; Coronary Angiograp

2016